Nurdan Aydin is an Investment Partner at Novo Nordisk, whose known portfolio counts 9 companies.
Is Nurdan Aydin a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechDiagnosticsDigital HealthDrug DiscoveryGenomicsMedTechObesity & Metabolic TherapeuticsPharmaRare Disease
Contacts
Affiliated funds' portfolios
Investment Partner at Novo Nordisk, whose known portfolio counts 9 companies
- Aspect Biosystems
- Cantoni Therapeutics
- ElevateBio
- Tanai Therapeutics
- Amalgam Rx
- The Sabi
- Eikonizo Therapeutics
- Proton HeartPet
- Ventus Therapeutics
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Diagnostics, Digital Health and Drug Discovery. Startups operating in these areas may find Nurdan Aydin relevant.
Stage-wise, the deals at Novo Nordisk cluster around Growth, Pre-Seed and Seed rounds.
What the affiliated firm has backed is the closest available signal on whether Nurdan Aydin is worth approaching.
Colleagues at Novo Nordisk
Ross Lindsay
Investor
Cambridge, United Kingdom
Asta Diabaté
Digital Open Innovation
London, United Kingdom
Emilie Bruun Poulsen
Senior Investment Partner
Copenhagen, Denmark
Josefin Melin
Lead Investment Partner
Copenhagen, Denmark
Saif Khaja
Associate Investment Partner
Rødovre, Denmark
Jonas Rasmussen
Investment Partner
Copenhagen, Denmark
Frequently asked questions
Who is Nurdan Aydin?
Nurdan Aydin is a corporate venture investor based in Holbæk, Denmark, listed as Investment Partner at Novo Nordisk. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to Nurdan Aydin personally.
What does Nurdan Aydin invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Diagnostics, Digital Health and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Nurdan Aydin invest at?
Novo Nordisk appears in Growth, Pre-Seed and Seed rounds across its known deals, and Nurdan Aydin is listed there as Investment Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Nurdan Aydin listed at?
Nurdan Aydin is listed as Investment Partner at Novo Nordisk. 6 other people in the database share a firm with Nurdan Aydin.
How do I contact Nurdan Aydin?
A LinkedIn page is on file for Nurdan Aydin. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal